Hot Features
Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodie... ImmunoPrecise Antibodies Ltd. is a biotechnology company that leverages multi-omics modeling and complex artificial intelligence through a series proprietary and patented technologies. The Company owns an integrated end-to-end suite of capabilities to support the development of therapeutic antibodies and are known for solving very complex industry challenges. IPA has several subsidiaries in North America and Europe including entities such as Talem Therapeutics LLC, BioStrand BV, ImmunoPrecise Antibodies (Canada) Ltd. and ImmunoPrecise Antibodies (Europe) B.V. (collectively, the "IPA Family"). Mehr anzeigen
ImmunoPrecise Antibodies Ltd. (NASDAQ : IPA) a annoncé ce jour le lancement de son pipeline alimenté par l'IA composé de produits thérapeutiques optimisés et nouveaux, un système visant à...
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) today announced the launch of its AI-powered pipeline of both optimized and new therapeutics, a system set to transform therapeutic development. By...
ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ : IPA) a annoncé aujourd'hui que Kristin Taylor avait démissionné de son poste de directrice financière à compter du 16 janvier 2025. Mme Taylor...
ImmunoPrecise Antibodies Ltd. (IPA) (NASDAQ: IPA) today announced that Kristin Taylor has resigned from her position as Chief Financial Officer effective January 16, 2025. Ms. Taylor will...
IPA (IMMUNOPRECISE ANTIBODIES LTD.) (la « société » ou « IPA ») (NASDAQ : IPA), une société de recherche et de technologie biothérapeutiques axée sur l’IA, est heureux d’annoncer une importante...
IPA (IMMUNOPRECISE ANTIBODIES LTD.) (the “Company” or “IPA”) (NASDAQ: IPA), an AI-driven biotherapeutic research and technology company, is pleased to announce significant insider activity, with...
IPA (IMMUNOPRECISE ANTIBODIES LTD.) (la « Société » ou « IPA ») (NASDAQ : IPA), une société de recherche et de technologie biothérapeutique basée sur l'IA, a annoncé aujourd'hui sa participation...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.0011 | 0.211538461538 | 0.52 | 0.59 | 0.4301 | 555336 | 0.53771028 | CS |
| 4 | 0.1341 | 34.6511627907 | 0.387 | 0.59 | 0.38 | 437522 | 0.50698564 | CS |
| 12 | -0.0363 | -6.51237890205 | 0.5574 | 0.6 | 0.3248 | 385775 | 0.45792871 | CS |
| 26 | -0.3089 | -37.2168674699 | 0.83 | 1.04 | 0.3248 | 374403 | 0.54754132 | CS |
| 52 | -1.0289 | -66.3806451613 | 1.55 | 2.6 | 0.3248 | 353944 | 1.10192098 | CS |
| 156 | -5.4989 | -91.3438538206 | 6.02 | 6.51 | 0.3248 | 146688 | 1.46716731 | CS |
| 260 | -19.4889 | -97.395802099 | 20.01 | 33.34 | 0.3248 | 269088 | 7.80665671 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
